MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 249.06 million in assets under management.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights is available below.

Items 1-25 of total 25
ComponentCountryWeight
ELI LILLY & COUS5.66%
CATALENT INCUS5.38%
BRISTOL-MYERS SQUIBB COUS5.19%
JOHNSON & JOHNSONUS5.03%
NOVARTIS AG-ADRCH4.95%
ABBVIE INCUS4.92%
NOVO-NORDISK A/S-SPONS ADRDK4.84%
SANOFI-ADRFR4.73%
MERCK & CO. INC.US4.72%
TEVA PHARMACEUTICAL-SP ADRIL4.66%
ASTRAZENECA PLC-SPONS ADRGB4.55%
AMERISOURCEBERGEN CORPUS4.50%
MCKESSON CORPUS4.41%
ZOETIS INCUS4.37%
GLAXOSMITHKLINE PLC-SPON ADRGB4.35%
VIATRIS INCUS4.26%
PFIZER INCUS4.21%
TAKEDA PHARM-ADRJP4.13%
JAZZ PHARMACEUTICALS PLCIE3.75%
BAUSCH HEALTH COS INCCA3.66%
ELANCO ANIMAL HEALTH INCUS2.56%
PERRIGO CO PLCIE2.12%
AMARIN CORPORATION PLC -ADRGB1.12%
GW PHARMACEUTICALS -ADRGB1.11%
PATTERSON COMPANIES INCUS0.83%
Items 1-25 of total 25
Up